お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
980743

バイオインフォマティクス市場:技術・サービス別、用途別、セクター別:世界の機会分析と業界予測(2020~2027年)

Bioinformatics Market by Technology & Services, Application, and Sector : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 284 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
バイオインフォマティクス市場:技術・サービス別、用途別、セクター別:世界の機会分析と業界予測(2020~2027年)
出版日: 2020年11月26日
発行: Allied Market Research
ページ情報: 英文 284 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオインフォマティクスの市場規模は2019年に86億1,429万米ドルとなりました。同市場は2020年から2027年にかけて13.4%のCAGRで拡大し、2027年までに247億3,161万米ドルに達すると予測されています。

バイオインフォマティクスは、さまざまな実験から得られたデータを分析するための情報技術、統計、分子生物学、およびアルゴリズムの組み合わせです。これには、生物学的データの収集、計算モデルの準備、計算モデリングの問題の解決、および計算アルゴリズムの評価が含まれます。バイオインフォマティクスは、コンピュテーションを使用して生物学的データからナレッジを抽出し、これは創薬や開発に使用できます。

世界のバイオインフォマティクス市場は、統合データの必要性の高まりとプロテオミクスおよびゲノミクスの応用拡大により、近い将来、大幅な成長を記録すると予想されます。さらに、創薬と開発は、予測期間中に市場の成長を後押しすることが期待されます。ただし、熟練した人員と共通したデータフォーマットが欠如していることが、予測期間中に市場の成長を妨げると予測されます。逆に、統合されたソリューションとシステムの必要性の増加は、市場のプレーヤーに豊富な機会を提供すると予想されます。

当レポートでは、バイオインフォマティクス市場について調査し、市場の概要とともに、技術・サービス別、用途別、セクター別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
    • 主な成功戦略
  • トッププレーヤーのポジショニング、2019年
  • 市場力学
    • 促進要因
      • 統合データの必要性の高まり
      • プロテオミクスとゲノミクスの成長の増加
      • 創薬と開発
    • 抑制要因
      • 熟練した人材の不足
      • 共通データフォーマット
    • 市場機会
      • 統合されたソリューションとシステムの必要性の高まり
  • ポーターのファイブフォース分析
  • 主な規制
  • バリューチェーン分析
  • 医薬品開発プロセスにおけるバイオインフォマティクス
  • 特許分析
  • ケーススタディ
  • 市場でのCOVID-19の影響分析
    • 概要
    • COVID-19がバイオインフォマティクス市場に与える影響

第4章 バイオインフォマティクス市場:技術・サービス別

  • 概要
    • 市場規模と予測
  • ナレッジマネジメントツール
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:タイプ別
      • 一般化された知識管理ツール
      • 専門の知識管理ツール
    • 市場規模と予測:地域別
    • 市場分析:国別
  • バイオインフォマティクスプラットフォーム
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:タイプ別
      • 配列分析プラットフォーム
      • 配列アラインメントプラットフォーム
      • シーケンス操作プラットフォーム
      • 構造解析プラットフォーム
      • その他
    • 市場規模と予測:地域別
    • 市場分析:国別
  • バイオインフォマティクスサービス
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:タイプ別
      • シーケンスサービス
      • データベース管理
      • データ解析
      • その他
    • 市場規模と予測:地域別
    • 市場分析:国別

第5章 バイオインフォマティクス市場:用途別

  • 概要
    • 市場規模と予測:地域別
  • ゲノミクス
    • 市場規模と予測:地域別
    • 市場分析:国別
  • ケモインフォマティクスとドラッグデザイン
    • 市場規模と予測:地域別
    • 市場分析:国別
  • プロテオミクス
    • 市場規模と予測:地域別
    • 市場分析:国別
  • トランスクリプトミクス
    • 市場規模と予測
    • 市場分析:国別
  • メタボロミクス
    • 市場規模と予測
    • 市場分析:国別
  • 分子系統学
    • 市場規模と予測
    • 市場分析:国別
  • その他
    • 市場規模と予測
    • 市場分析:国別

第6章 世界のバイオインフォマティクス市場:セクター別

  • 概要
    • 市場規模と予測:地域別
  • 医療バイオインフォマティクス
    • 市場規模と予測:地域別
    • 市場分析:国別
  • 動物バイオインフォマティクス
    • 市場規模と予測:地域別
    • 市場分析:国別
  • 農業バイオインフォマティクス
    • 市場規模と予測:地域別
    • 市場分析:国別
  • 学術
    • 市場規模と予測:地域別
    • 市場分析:国別
  • その他
    • 市場規模と予測:地域別
    • 市場分析:国別

第7章 バイオインフォマティクス市場:地域別

  • 概要
    • 市場規模と予測
  • 北米
    • 主要な市場動向と機会
    • 北米のバイオインフォマティクス市場:国別
      • 米国のバイオインフォマティクス市場:技術・サービス別
      • 米国のバイオインフォマティクス市場:用途別
      • 米国のバイオインフォマティクス市場:セクター別
      • カナダのバイオインフォマティクス市場:技術・サービス別
      • カナダのバイオインフォマティクス市場:用途別
      • カナダのバイオインフォマティクス市場:セクター別
      • メキシコのバイオインフォマティクス市場:技術・サービス別
      • メキシコのバイオインフォマティクス市場:用途別
      • メキシコのバイオインフォマティクス市場:セクター別
    • 北米のバイオインフォマティクス市場:技術・サービス別
    • 北米のバイオインフォマティクス市場:用途別
    • 北米のバイオインフォマティクス市場:セクター別
  • 欧州
    • 主要な市場動向と機会
    • 欧州のバイオインフォマティクス市場:国別
      • ドイツのバイオインフォマティクス市場:技術・サービス別
      • ドイツのバイオインフォマティクス市場:用途別
      • ドイツのバイオインフォマティクス市場:セクター別
      • フランスのバイオインフォマティクス市場:技術・サービス別
      • フランスのバイオインフォマティクス市場:用途別
      • フランスのバイオインフォマティクス市場:セクター別
      • 英国のバイオインフォマティクス市場:技術・サービス別
      • 英国のバイオインフォマティクス市場:用途別
      • 英国のバイオインフォマティクス市場:セクター別
      • イタリアのバイオインフォマティクス市場:技術・サービス別
      • イタリアのバイオインフォマティクス市場:用途別
      • イタリアのバイオインフォマティクス市場:セクター別
      • スペインのバイオインフォマティクス市場:技術・サービス別
      • スペインのバイオインフォマティクス市場:用途別
      • スペインのバイオインフォマティクス市場:セクター別
      • その他欧州のバイオインフォマティクス市場:技術・サービス別
      • その他欧州のバイオインフォマティクス市場:用途別
      • その他欧州のバイオインフォマティクス市場:セクター別
    • 欧州のバイオインフォマティクス市場:技術・サービス別
    • 欧州のバイオインフォマティクス市場:用途別
    • 欧州のバイオインフォマティクス市場:セクター別
  • アジア太平洋
    • 主要な市場動向と機会
    • アジア太平洋のバイオインフォマティクス市場:国別
      • 日本のバイオインフォマティクス市場:技術・サービス別
      • 日本のバイオインフォマティクス市場:用途別
      • 日本のバイオインフォマティクス市場:セクター別
      • 中国のバイオインフォマティクス市場:技術・サービス別
      • 中国のバイオインフォマティクス市場:用途別
      • 中国のバイオインフォマティクス市場:セクター別
      • インドのバイオインフォマティクス市場:技術・サービス別
      • インドのバイオインフォマティクス市場:用途別
      • インドのバイオインフォマティクス市場:セクター別
      • オーストラリアのバイオインフォマティクス市場:技術・サービス別
      • オーストラリアのバイオインフォマティクス市場:用途別
      • オーストラリアのバイオインフォマティクス市場:セクター別
      • 韓国のバイオインフォマティクス市場:技術・サービス別
      • 韓国のバイオインフォマティクス市場:用途別
      • 韓国のバイオインフォマティクス市場:セクター別
      • 台湾のバイオインフォマティクス市場:技術・サービス別
      • 台湾のバイオインフォマティクス市場:用途別
      • 台湾のバイオインフォマティクス市場:セクター別
      • その他アジア太平洋地域のバイオインフォマティクス市場:技術・サービス別
      • その他アジア太平洋地域のバイオインフォマティクス市場:用途別
      • その他アジア太平洋地域のバイオインフォマティクス市場:セクター別
    • アジア太平洋のバイオインフォマティクス市場:技術・サービス別
    • アジア太平洋のバイオインフォマティクス市場:用途別
    • アジア太平洋のバイオインフォマティクス市場:セクター別
  • LAMEA
    • 主要な市場動向と機会
    • LAMEAバイオインフォマティクス市場:国別
      • ブラジルのバイオインフォマティクス市場:技術・サービス別
      • ブラジルのバイオインフォマティクス市場:用途別
      • ブラジルのバイオインフォマティクス市場:セクター別
      • サウジアラビアのバイオインフォマティクス市場:技術・サービス別
      • サウジアラビアのバイオインフォマティクス市場:用途別
      • サウジアラビアのバイオインフォマティクス市場:セクター別
      • 南アフリカのバイオインフォマティクス市場:技術・サービス別
      • 南アフリカのバイオインフォマティクス市場:用途別
      • 南アフリカのバイオインフォマティクス市場:セクター別
      • LAMEAバイオインフォマティクス市場の残りの部分:技術・サービス別
      • LAMEAバイオインフォマティクス市場の残りの部分:用途別
      • LAMEAバイオインフォマティクス市場の残りの部分:セクター別
    • LAMEAバイオインフォマティクス市場:技術・サービス別
    • LAMEAバイオインフォマティクス市場:用途別
    • LAMEAバイオインフォマティクス市場:セクター別

第8章 企業プロファイル

  • AGILENT TECHNOLOGIES, INC.
  • BIOMAX INFORMATICS AG
  • DNANEXUS, INC.
  • GENEDATA AG
  • INTREXON BIOINFORMATICS GERMANY GMBH
  • ILLUMINA, INC.
  • PERKINELMER, INC.
  • QIAGEN N.V.
  • SEVEN BRIDGES GENOMICS INC.
  • THERMO FISHER SCIENTIFIC, INC.
図表

LIST OF TABLES

  • TABLE 01.BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 02.BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 03.BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 05.BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 07.BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.BIOINFORMATICS MARKET, BY APPLICATION 2019-2027 ($MILLION)
  • TABLE 09.BIOINFORMATICS MARKET FOR GENOMICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 10.BIOINFORMATICS MARKET FOR CHEMOINFORMATICS & DRUG DESIGN, BY REGION 2019-2027 ($MILLION)
  • TABLE 11.BIOINFORMATICS MARKET FOR PROTEOMICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 12.BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 13.BIOINFORMATICS MARKET FOR METABOLOMICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 14.BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.BIOINFORMATICS MARKET FOR OTHERS, BY REGION 2019-2027 ($MILLION)
  • TABLE 16.BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 17.BIOINFORMATICS MARKET FOR MEDICAL BIOINFORMATICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 18.BIOINFORMATICS MARKET FOR ANIMAL BIOINFORMATICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 19.BIOINFORMATICS MARKET FOR AGRICULTURE BIOINFORMATICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 20.BIOINFORMATICS MARKET FOR ACADEMICS, BY REGION 2019-2027 ($MILLION)
  • TABLE 21.BIOINFORMATICS MARKET FOR OTHERS, BY REGION 2019-2027 ($MILLION)
  • TABLE 22.BIOINFORMATICS MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 23.NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 24.U.S. BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 25.U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 26.U.S. BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 27.CANADA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 28.CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 29.CANADA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 30.MEXICO BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 31.MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 32.MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 33.NORTH AMERICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 34.NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 35.NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 36.EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 37.GERMANY BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 38.GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 39.GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 40.FRANCE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 41.FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 42.FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 43.UK BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 44.UK BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 45.UK BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 46.ITALY BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 47.ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 48.ITALY BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 49.SPAIN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 50.SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 51.SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 52.REST OF EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 53.REST OF EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 54.REST OF EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 55.EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 56.EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 57.EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 58.ASIA-PACIFIC BIOINFORMATICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 59.JAPAN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 60.JAPAN BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 61.JAPAN BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 62.CHINA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 63.CHINA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 64.CHINA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 65.INDIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 66.INDIA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 67.INDIA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 68.AUSTRALIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 69.AUSTRALIA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 70.AUSTRALIA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 71.SOUTH KOREA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 72.SOUTH KOREA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 73.SOUTH KOREA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 74.TAIWAN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 75.TAIWAN BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 76.TAIWAN BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 77.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 78.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 79.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 80.ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 81.ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 82.ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 83.LAMEA BIOINFORMATICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 84.BRAZIL BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 85.BRAZIL BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 86.BRAZIL BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 87.SAUDI ARABIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 88.SAUDI ARABIA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 89.SAUDI ARABIA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 90.SOUTH AFRICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 91.SOUTH AFRICA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 92.SOUTH AFRICA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 93.REST OF LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 94.REST OF LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 95.REST OF LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 96.LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019-2027 ($MILLION)
  • TABLE 97.LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 98.LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2019-2027 ($MILLION)
  • TABLE 99.AGILENT: COMPANY SNAPSHOT
  • TABLE 100.AGILENT: OERATING SEGMENT
  • TABLE 101.AGILENT: PRODUCT PORTFOLIO
  • TABLE 102.BIOMAX INFORMATICS : COMPANY SNAPSHOT
  • TABLE 103.BIOMAX INFORMATICS : OPERATING SEGMENTS
  • TABLE 104.BIOMAX INFORMATICS: PRODUCT PORTFOLIO
  • TABLE 105.DNANEXUS: COMPANY SNAPSHOT
  • TABLE 106.DNANEXUS: OPERATING SEGMENTS
  • TABLE 107.DNANEXUS: PRODUCT PORTFOLIO
  • TABLE 108.GENEDATA: COMPANY SNAPSHOT
  • TABLE 109.GENEDATA: OPERATING SEGMENTS
  • TABLE 110.GENEDATA: PRODUCT PORTFOLIO
  • TABLE 111.INTREXON: COMPANY SNAPSHOT
  • TABLE 112.INTREXON: OPERATING SEGMENTS
  • TABLE 113.INTREXON: PRODUCT PORTFOLIO
  • TABLE 114.ILLUMINA: COMPANY SNAPSHOT
  • TABLE 115.ILLUMINA: OPERATING SEGMENTS
  • TABLE 116.ILLUMINA: PRODUCT PORTFOLIO
  • TABLE 117.PERKINELMER: COMPANY SNAPSHOT
  • TABLE 118.PERKINELMER: OPERATING SEGMENT
  • TABLE 119.PERKINELMER: PRODUCT PORTFOLIO
  • TABLE 120.QIAGEN: COMPANY SNAPSHOT
  • TABLE 121.QIAGEN: PRODUCT SEGMENT
  • TABLE 122.QIAGEN: PRODUCT PORTFOLIO
  • TABLE 123.SEVEN BRIDGES: COMPANY SNAPSHOT
  • TABLE 124.SEVEN BRIDGES: OPERATING SEGMENTS
  • TABLE 125.SEVEN BRIDGES: PRODUCT PORTFOLIO
  • TABLE 126.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
  • TABLE 127.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENT
  • TABLE 128.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.TOP INVESTMENT POCKETS, 2019
  • FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2018-2020*
  • FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020* (%)
  • FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020*
  • FIGURE 05.TOP PLAYER POSITIONING, 2019
  • FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 09.MODERATE THREAT OF NEW ENTRANT
  • FIGURE 10.HIIGH COMPETITIVE RIVALRY
  • FIGURE 11.VALUE CHAIN ANALYSIS
  • FIGURE 12.PATENTS ANALYSIS BY YEAR, 2017 TO 2019
  • FIGURE 13.PATENT ANALYSIS, BY COUNTRY (2017-2019)
  • FIGURE 14.PATENT ANALYSIS, BY APPLICANT (2017-2019)
  • FIGURE 15.GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, 2019-2027 ($MILLION)
  • FIGURE 16.SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, 2019-2027 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 18.SEQUENCE ANALYSIS PLATFORM MARKET, 2019-2027 ($MILLION)
  • FIGURE 19.SEQUENCE ALIGNMENT PLATFORM MARKET, 2019-2027 ($MILLION)
  • FIGURE 20.SEQUENCE MANIPULATION PLATFORMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 21.STRUCTURAL ANALYSIS PLATFORMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 22.OTHER BIOINFORMATICS PLATFORM MARKET, 2019-2027 ($MILLION)
  • FIGURE 23.COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 24.SEQUENCE SERVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 25.DATABASE MANAGEMENT BIOINFORMATICS MARKET, 2019-2027 ($MILLION)
  • FIGURE 26.DATA ANALYSIS BIOINFORMATICS MARKET, 2019-2027 ($MILLION)
  • FIGURE 27.OTHERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 28.COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR GENOMICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR CHEMOINFORMATICS AND DRUG DESIGN, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 31.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR PROTEOMICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 32.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 33.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR METABOLOMICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 34.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 35.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET OTHERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 36.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR MEDICAL BIOINFORMATICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 37.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR ANIMAL BIOINFORMATICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 38.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR AGRICULTURE BIOINFORMATICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 39.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR ACADEMICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 40.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 41.AGILENT: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 42.AGILENT: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 43.AGILENT: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 44.ILLUMINA: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 45.ILLUMINA: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 46.ILLUMINA: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 47.PERKINELMER: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 48.PERKINELMER: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 49.PERKINELMER: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 50.QIAGEN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 51.QIAGEN: REVENUE SHARE, BY PRODUCT, 2019 (%)
  • FIGURE 52.QIAGEN: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 53.THERMO FISHER SCIENTIFIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 54.THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 55.THERMO FISHER SCIENTIFIC. REVENUE SHARE, BY REGION, 2019 (%)
目次
Product Code: A00056

Title:
Bioinformatics Market by Technology & Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services), Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, and Others), and Sector (Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global bioinformatics market generated $8,614.29 million in 2019, and is projected to reach $24,731.61 million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.

Bioinformatics is the combination of information technology, statistics, molecular biology, and algorithms to analyze the data obtained from various experiments. It includes collecting biological data, preparation of a computational model, solving computational modeling problems, and evaluation of computational algorithm. Bioinformatics uses computation to extract knowledge from biological data, which can be used in drug discovery and developments.

The global bioinformatics market is expected to register substantial growth in the near future, owing to rise in need for integrated data and increase in applications of proteomics & genomics. In addition, drug discovery & development is expected to boost the market growth during the forecast period. However, lack of skilled personnel and common data formats is projected to hamper the market growth during the forecast period. Conversely, increase in need for integrated solutions & systems is expected to offer lucrative opportunities for market players.

The global bioinformatics market is segmented based on technology & services, application, sector, and region. By technology, the market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. Based on application, it is classified into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics, and others. Depending on sector, it is segregated into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the global bioinformatics market is provided.

KEY MARKET SEGMENTS

By Technology & Services

Knowledge Management Tools

Generalized Knowledge Management Tools

Specialized Knowledge Management Tools

Bioinformatics Platforms

Sequence Analysis Platforms

Sequence Alignment Platforms

Sequence Manipulation Platforms

Structural Analysis Platforms

Others

Bioinformatics Services

Sequencing Services

Database Management

Data Analysis

Others

By Application

Metabolomics

Molecular Phylogenetics

Transcriptomics

Proteomics

Chemoinformatics

Genomics

Others

By Sector

Medical Bioinformatics

Animal Bioinformatics

Agriculture Bioinformatics

Academics

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Australia

Japan

India

China

South Korea

Rest of Asia-Pacific

LAMEA

Brazil

Saudi Arabia

South Africa

Rest of LAMEA

KEY MARKET PLAYERS

Agilent Technologies, Inc.

Biomax Informatics AG

DNAnexus, Inc.

Genedata AG

Intrexon Bioinformatics Germany GmbH

Illumina Inc.

Perkinelmer Inc.

Qiagen N.V.

Seven Bridges Genomics Inc.

Thermo Fisher Scientific, Inc.

The other players in the value chain include (profiles not included in the report):

  • Geneva Bioinformatics (Genebio)
  • Dassault Systems
  • Eurofins Scientific
  • Bruker Daltonics Inc.
  • Accelrys, Inc.
  • Affymetrix, Inc.
  • SA Nonlinear Dynamics
  • Quest Diagnostics, Inc., and among others

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Top player positioning, 2019
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Rise in need for integrated data
      • 3.4.1.2.Increase in growth in proteomics & genomics
      • 3.4.1.3.Drug discovery and development
    • 3.4.2.Restraints
      • 3.4.2.1.Lack of skilled personnel
      • 3.4.2.2.Common data formats
    • 3.4.3.Opportunity
      • 3.4.3.1.Increase in need for integrated solutions & systems
  • 3.5.Porter's five forces analysis
  • 3.6.Key regulations
  • 3.7.Value chain analysis
  • 3.8.Bioinformatics in the drug development process
  • 3.9.Patent analysis
  • 3.10.Case studies
  • 3.11.Impact analysis of COVID-19 on market
    • 3.11.1.Overview
    • 3.11.2.Impact of COVID-19 on bioinformatics market

CHAPTER 4:BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Knowledge management tools
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by type
      • 4.2.2.1.Generalized knowledge management tools
      • 4.2.2.1.1.Market size and forecast
      • 4.2.2.2.Specialized knowledge management tools
      • 4.2.2.2.1.Market size and forecast
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
  • 4.3.Bioinformatics platforms
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by type
      • 4.3.2.1.Sequence analysis platforms
      • 4.3.2.1.1.Market size and forecast
      • 4.3.2.2.Sequence alignment platforms
      • 4.3.2.2.1.Market size and forecast
      • 4.3.2.3.Sequence manipulation platforms
      • 4.3.2.3.1.Market size and forecast
      • 4.3.2.4.Structural analysis platforms
      • 4.3.2.4.1.Market size and forecast
      • 4.3.2.5.Others
      • 4.3.2.5.1.Market size and forecast
    • 4.3.3.Market size and forecast, by region
    • 4.3.4.Market analysis, by country
  • 4.4.Bioinformatics services
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by type
      • 4.4.2.1.Sequence services
      • 4.4.2.1.1.Market size and forecast
      • 4.4.2.2.Database management
      • 4.4.2.2.1.Market size and forecast
      • 4.4.2.3.Data analysis
      • 4.4.2.3.1.Market size and forecast
      • 4.4.2.4.Others
      • 4.4.2.4.1.Market size and forecast
    • 4.4.3.Market size and forecast, by region
    • 4.4.4.Market analysis, by country

CHAPTER 5:BIOINFORMATICS MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast, by region
  • 5.2.Genomics
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Chemoinformatics & drug design
    • 5.3.1.Market Size and Forecast, By Region
    • 5.3.2.Market analysis, by country
  • 5.4.Proteomics
    • 5.4.1.Market Size and Forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Transcriptomics
    • 5.5.1.Market size and forecast
    • 5.5.2.Market analysis, by country
  • 5.6.Metabolomics
    • 5.6.1.Market size and forecast
    • 5.6.2.Market analysis, by country
  • 5.7.Molecular phylogenetics
    • 5.7.1.Market size and forecast
    • 5.7.2.Market analysis, by country
  • 5.8.Others
    • 5.8.1.Market size and forecast
    • 5.8.2.Market analysis, by country

CHAPTER 6:GLOBAL BIOINFORMATICS MARKET, BY SECTOR

  • 6.1.Overview
    • 6.1.1.Market size and forecast, by region
  • 6.2.Medical bioinformatics
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Animal bioinformatics
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
  • 6.4.Agricultural bioinformatics
    • 6.4.1.Market size and forecast by region
    • 6.4.2.Market analysis, by country
  • 6.5.Academics
    • 6.5.1.Market size and forecast, by region
    • 6.5.2.Market analysis, by country
  • 6.6.Others
    • 6.6.1.Market size and forecast, by region
    • 6.6.2.Market analysis, by country

CHAPTER 7:BIOINFORMATICS MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends and opportunities
    • 7.2.2.North America bioinformatics market, by country
      • 7.2.2.1.U.S. bioinformatics market, by technology & services
      • 7.2.2.2.U.S. bioinformatics market, by application
      • 7.2.2.3.U.S. bioinformatics market, by sector
      • 7.2.2.4.Canada bioinformatics market, by technology & services
      • 7.2.2.5.Canada bioinformatics market, by application
      • 7.2.2.6.Canada bioinformatics market, by sector
      • 7.2.2.7.Mexico bioinformatics market, by technology & services
      • 7.2.2.8.Mexico bioinformatics market, by application
      • 7.2.2.9.Mexico bioinformatics market, by sector
    • 7.2.3.North America bioinformatics market, by technology & services
    • 7.2.4.North America bioinformatics market, by application
    • 7.2.5.North America bioinformatics market, by sector
  • 7.3.Europe
    • 7.3.1.Key market trends and opportunities
    • 7.3.2.Europe bioinformatics market, by country
      • 7.3.2.1.Germany bioinformatics market, by technology & services
      • 7.3.2.2.Germany bioinformatics market, by application
      • 7.3.2.3.Germany bioinformatics market, by sector
      • 7.3.2.4.France bioinformatics market, by technology & services
      • 7.3.2.5.France bioinformatics market, by application
      • 7.3.2.6.France bioinformatics market, by sector
      • 7.3.2.7.UK bioinformatics market, by technology & services
      • 7.3.2.8.UK bioinformatics market, by application
      • 7.3.2.9.UK bioinformatics market, by sector
      • 7.3.2.10.Italy bioinformatics market, by technology & services
      • 7.3.2.11.Italy bioinformatics market, by application
      • 7.3.2.12.Italy bioinformatics market, by sector
      • 7.3.2.13.Spain bioinformatics market, by technology & services
      • 7.3.2.14.Spain bioinformatics market, by application
      • 7.3.2.15.Spain bioinformatics market, by sector
      • 7.3.2.16.Rest of Europe bioinformatics market, by technology & services
      • 7.3.2.17.Rest of Europe bioinformatics market, by application
      • 7.3.2.18.Rest of Europe bioinformatics market, by sector
    • 7.3.3.Europe bioinformatics market, by technology & services
    • 7.3.4.Europe bioinformatics market, by application
    • 7.3.5.Europe bioinformatics market, by sector
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends and opportunities
    • 7.4.2.Asia-Pacific bioinformatics market, by country
      • 7.4.2.1.Japan bioinformatics market, by technology & services
      • 7.4.2.2.Japan bioinformatics market, by application
      • 7.4.2.3.Japan bioinformatics market, by sector
      • 7.4.2.4.China bioinformatics market, by technology & services
      • 7.4.2.5.China bioinformatics market, by application
      • 7.4.2.6.China bioinformatics market, by sector
      • 7.4.2.7.India bioinformatics market, by technology & services
      • 7.4.2.8.India bioinformatics market, by application
      • 7.4.2.9.India bioinformatics market, by sector
      • 7.4.2.10.Australia bioinformatics market, by technology & services
      • 7.4.2.11.Australia bioinformatics market, by application
      • 7.4.2.12.Australia bioinformatics market, by sector
      • 7.4.2.13.South Korea bioinformatics market, by technology & services
      • 7.4.2.14.South Korea bioinformatics market, by application
      • 7.4.2.15.South Korea bioinformatics market, by sector
      • 7.4.2.16.Taiwan bioinformatics market, by technology & services
      • 7.4.2.17.Taiwan bioinformatics market, by application
      • 7.4.2.18.Taiwan bioinformatics market, by sector
      • 7.4.2.19.Rest of Asia-Pacific bioinformatics market, by technology & services
      • 7.4.2.20.Rest of Asia-Pacific bioinformatics market, by application
      • 7.4.2.21.Rest of Asia-Pacific bioinformatics market, by sector
    • 7.4.3.Asia-Pacific bioinformatics market, by technology & services
    • 7.4.4.Asia-Pacific bioinformatics market, by application
    • 7.4.5.Asia-Pacific bioinformatics market, by sector
  • 7.5.LAMEA
    • 7.5.1.Key market trends and opportunities
    • 7.5.2.LAMEA bioinformatics market, by country
      • 7.5.2.1.Brazil bioinformatics market, by technology & services
      • 7.5.2.2.Brazil bioinformatics market, by application
      • 7.5.2.3.Brazil bioinformatics market, by sector
      • 7.5.2.4.Saudi Arabia bioinformatics market, by technology & services
      • 7.5.2.5.Saudi Arabia bioinformatics market, by application
      • 7.5.2.6.Saudi Arabia bioinformatics market, by sector
      • 7.5.2.7.South Africa bioinformatics market, by technology & services
      • 7.5.2.8.South Africa bioinformatics market, by application
      • 7.5.2.9.South Africa bioinformatics market, by sector
      • 7.5.2.10.Rest of LAMEA bioinformatics market, by technology & services
      • 7.5.2.11.Rest of LAMEA bioinformatics market, by application
      • 7.5.2.12.Rest of LAMEA bioinformatics market, by sector
    • 7.5.3.LAMEA bioinformatics market, by technology & services
    • 7.5.4.LAMEA bioinformatics market, by application
    • 7.5.5.LAMEA bioinformatics market, by sector

CHAPTER 8:COMPANY PROFILES

  • 8.1.AGILENT TECHNOLOGIES, INC.
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
  • 8.2.BIOMAX INFORMATICS AG
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product Portfolio
    • 8.2.5.Key strategic moves and developments
  • 8.3.DNANEXUS, INC.
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Key strategic moves and developments
  • 8.4.GENEDATA AG
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
  • 8.5.INTREXON BIOINFORMATICS GERMANY GMBH
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Key strategic moves and developments
  • 8.6.ILLUMINA, INC.
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Business performance
    • 8.6.6.Key strategic moves and developments
  • 8.7.PERKINELMER, INC.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Business performance
  • 8.8.QIAGEN N.V.
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segment
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.SEVEN BRIDGES GENOMICS INC.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product Portfolio
    • 8.9.5.Key strategic moves and developments
  • 8.10.THERMO FISHER SCIENTIFIC, INC.
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segment
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.